Browse Related Topics:

LOCKED Decisions in Action, Delivery in Practice: Adding Flurpiridaz F-18 to Cardiac PET Programs

Published on: May 1, 2026

While Cardiac PET continues to expand, adding a new isotope requires complex operational and financial decisions beyond image quality. In this session, a cardiovascular imaging leader will share their end-to-end approach to implementing Flurpiridaz F-18, from building business cards to adjusting workflows, staffing, scheduling and prior authorization. Attendees will receive a practical, high-level overview of best practices for evaluating and scaling a cardiac PET program.

Speakers:

  • Jaime Warren, Ed.D., MBA, BHS, CNMT, NCT, Vice President, Care Transformation Services, MedAxiom
  • William Cuningham, MBA, Director of Imaging, Sanger Heart & Vascular Institute, Atrium Health
Ok
This site uses cookies to improve your experience.

By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.